Viewing Study NCT07010705


Ignite Creation Date: 2025-12-25 @ 3:14 AM
Ignite Modification Date: 2026-02-26 @ 12:36 AM
Study NCT ID: NCT07010705
Status: RECRUITING
Last Update Posted: 2025-09-15
First Post: 2025-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Digital Measures for Clinical Trial Endpoints in Huntington's Disease
Sponsor: University of Rochester
Organization:

Study Overview

Official Title: Digital Measures for Clinical Trial Endpoints in Huntington's Disease (MEND-HD)
Status: RECRUITING
Status Verified Date: 2025-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MEND-HD
Brief Summary: MEND-HD is a longitudinal study evaluating the feasibility of passive monitoring of gait and chorea in patients with HD and the meaningfulness of these outcomes for patients with HD and their care partners/support persons.

Participants will take part in four virtual visits with study investigators to answer survey questions on movement and cognition, perform in-home movement assessments, and take part in an interview regarding the meaningfulness of gait and chorea in their daily lives.

Participant and care partner interviews will be used for symptom mapping and qualitative data analysis to assess the relevance and impact of the targeted symptoms on the participant's daily life.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
1U01FD008429-01 FDA None https://reporter.nih.gov/quic… View